Ambrx Biopharma Inc – The Muslim

Tuesday, February 4, 2025

Latest:

Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth

Business & Finance

adminsr January 14, 2024 ADC Therapeutics SA, Ambrx Biopharma Inc, AstraZeneca PLC, Biotech and Pharmaceuticals, Biotechnology, Breaking news, Business, business news, Daiichi Sankyo Co Ltd, GSK plc, Health care industry, Johnson & Johnson, JPMORGAN DRN, Merck & Co Inc, Pfizer Inc, Pharmaceuticals, San Francisco, Sanofi SA, Science, Seagen Inc, United States

Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth

[ad_1] Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture

Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch

Business & Finance

adminsr December 28, 2023 Abbvie Inc, Ambrx Biopharma Inc, Amgen Inc, Apogee Therapeutics Inc, AstraZeneca PLC, Biohaven Ltd, Biotech and Pharmaceuticals, Bristol-Myers Squibb Co, business news, Cerevel Therapeutics Holdings Inc, Eli Lilly and Co, Exelixis Inc, Gracell Biotechnologies Inc, Health care industry, ImmunoGen Inc, Investment strategy, Karuna Therapeutics Inc, Madrigal Pharmaceuticals Inc, NASDAQ Biotechnology Index, POINT Biopharma Global Inc, RayzeBio Inc, Spdr S&P Biotech Etf, Vertex Pharmaceuticals Inc

Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch

[ad_1] Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin